KURA (Kura Oncology) Insider Ownership: 2.03 % (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KURA Kura Oncology Inc KURA
28 GF Score
Price $11.71
! 8 Warning Signs
View Full Analysis

What is Kura Oncology Insider Ownership?

Kura Oncology KURA -6.51% 28 Insider Ownership is 2.03 % as of Aug. 20, 2026. GuruFocus rates KURA with a GF Score™ of 28/100. The stock has 8 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kura Oncology's insider ownership is 2.03%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kura Oncology's Institutional Ownership is 95.75%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kura Oncology's Float Percentage Of Total Shares Outstanding is 97.41%.

Kura Oncology Insider Ownership Historical Data

* Premium members only.

The historical data trend for Kura Oncology's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kura Oncology Insider Ownership Chart

Kura Oncology Historical Data

The historical data trend for Kura Oncology can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 0.96 1.02 1.49 1.49 1.94 2.17 2.17 2.13 2.03 2.03
KURA
28GF Score
Kura Oncology Inc KURA
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kura Oncology Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 2.03 % mean?
Kura Oncology (KURA) has a Insider Ownership of 2.03 % as of Aug. 20, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Kura Oncology and its competitors.
Is Kura Oncology's Insider Ownership too high?
Kura Oncology's current Insider Ownership is 2.03 %. Overall, Kura Oncology has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Kura Oncology's Insider Ownership compare to PHAT and GERN?
Kura Oncology's Insider Ownership of 2.03 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Kura Oncology and its competitors. Kura Oncology's current Insider Ownership is 2.03 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kura Oncology stock overvalued right now?
Kura Oncology (KURA) has a current Insider Ownership of 2.03 %. The current Insider Ownership is 2.03 %. Kura Oncology's overall GF Score™ is 28/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Kura Oncology (KURA), the current Insider Ownership is 2.03 % as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kura Oncology Business Description

Other Exchanges KUR:Germany
Address 4930 Directors Place, Suite 500, San Diego, CA, USA, 92121
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
28GF Score

Get the complete analysis for KURA

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.71
Price